Pharma stocks rise 5% within 90 days of new FDA chief

Major pharma companies will see a 5% or greater stock price increase within 90 days of a new FDA commissioner being confirmed. This reflects investor confidence in policy stability and faster approval timelines.

Implied probability (Yes)

60%